Acute chest pain (ACP) is one of the most common reasons for emergency department visits globally. It poses a diagnostic challenge due to its diverse etiologies, which range from benign musculoskeletal disorders to life-threatening conditions like acute coronary syndrome (ACS). This article aims to provide a comprehensive approach to the evaluation and management of ACP.
Initial assessment should focus on patient history, physical examination, and electrocardiogram (ECG). These can provide crucial clues about the underlying cause. History should include the PQRST (Provocation, Quality, Radiation, Severity, Timing) of pain, associated symptoms, and risk factors for coronary artery disease. An ECG should be obtained within 10 minutes of presentation.
Cardiac biomarkers, particularly troponins, play a key role in the diagnosis of ACS. High-sensitivity troponin assays have improved the early detection of myocardial injury. However, elevated troponins can also be seen in non-cardiac conditions, necessitating careful interpretation.
When initial evaluation is inconclusive, imaging studies can be invaluable. Chest radiography, echocardiography, and computed tomography (CT) angiography are commonly used. CT angiography is particularly useful in evaluating for pulmonary embolism and aortic dissection.
Risk stratification helps guide management. Patients at low risk for ACS may undergo outpatient evaluation, while those at high risk require hospital admission. Various risk scores like the HEART score can assist in this process.
The approach to ACP involves a combination of clinical assessment, biomarker testing, imaging studies, and risk stratification. A systematic and comprehensive approach can help ensure that life-threatening causes are not missed, while also avoiding unnecessary hospital admissions for low-risk patients. Continuing research and advancements in diagnostic modalities promise to further refine this approach in the future.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation